Bone Biologics Corp (NASDAQ: BBLG) — Healthcare · Share Price, Chart & Market Data
About: Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.37 (+0.74%)
BBLGBone Biologics Corp
Loading watchlist status…
Trade BBLG now
Bone Biologics Corp share price
BBLG price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 5:18 pm GMT+0
BBLG price performance
-1.792%
5D
23.423%
1M
-11.039%
YTD
-65.404%
1Y
BBLG price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 5:18 pm GMT+0
BBLG details
BBLG Market Signals